Background: The current incidence of major complications in paediatric craniofacial surgery in North America has not been accurately defined. In this report, the Pediatric Craniofacial Collaborative Group evaluates the incidence and determines the independent predictors of major perioperative complications using a multicentre database. Methods: The Pediatric Craniofacial Surgery Perioperative Registry was queried for subjects undergoing complex cranial vault reconstruction surgery over a 5-year period. Major perioperative complications were identified through a structured a priori consensus process. Logistic regression was applied to identify predictors of a major perioperative complication with bootstrapping to evaluate discrimination accuracy and provide internal validity of the multivariable model. Results: A total of 1814 patients from 33 institutions in the US and Canada were analysed; 15% were reported to have a major perioperative complication. Multivariable predictors included ASA physical status 3 or 4 (P¼0.005), craniofacial syndrome (P¼0.008), antifibrinolytic administered (P¼0.003), blood product transfusion >50 ml kg e1 (P<0.001), and surgery duration over 5 h (P<0.001). Bootstrapping indicated that the predictive algorithm had good internal validity and excellent
discrimination and model performance. A perioperative complication was estimated to increase the hospital length of stay by an average of 3 days (P<0.001). Conclusions: The predictive algorithm can be used as a prognostic tool to risk stratify patients and thereby potentially reduce morbidity and mortality. Craniofacial teams can utilise these predictors of complications to identify high-risk patients. Based on this information, further prospective quality improvement initiatives may decrease complications, and reduce morbidity and mortality.
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Editor's key points
Craniosynostosis occurs when one or more of the cranial sutures fuse prematurely. Complex cranial vault reconstruction procedures are performed to prevent or limit neurological impairment. The authors interrogated a prospectively collected database involving >1800 children from 33 centres to identify the incidence of, and risk factors, for complications. The incidence of major complications was 15%, and the risk factor analysis enabled development of a predictive tool that may help with risk stratification.
The morbidity and mortality rates for paediatric complex cranial vault reconstruction (CCVR) surgery in the past decade have been reported to be as high as 40% and as low as 0%. 1À12 CCVR is an open surgical procedure undertaken at a young age to correct craniosynostosis in a timely fashion in order to prevent or limit neurological impairment. Advancements in surgical and anaesthesia perioperative care have likely led to a decline in morbidity and mortality, however the current incidence of complications in open craniosynostosis surgery has not been consistently or accurately defined. Considerable variability of reported perioperative complication rates is partially attributable to inconsistent classification systems for major complications and discordance on what in fact constitutes a complication vs expected sequelae from surgery. 1À12 In addition, a multicentre benchmarking study from our Pediatric Craniofacial Collaborative Group (PCCG) reports that, currently, more than 90% of cases are admitted to Intensive Care Units postoperatively, which supports awareness of the acuity and significant risks involved with CCVR surgery. 13 (Listing of collaborator names supplied in Supplementary Appendix S1.) In a recent report, the incidence of major adverse events in one United States tertiary care centre was~15% for this surgery.
14 Independent predictors were patient body weight <10 kg, American Society of Anesthesiologists (ASA) physical status 3 or 4, packed red blood cell (PRBC) transfusion >60 ml kg
À1
, haemostatic blood product (i.e. plasma, platelets, and cryoprecipitate) transfusion, or lack of utilisation of antifibrinolytics. Tranexamic acid administration was associated with significantly fewer postoperative complications. 14, 15 In the present study, we define the incidence and determine the risk factors for major perioperative complications in CCVR using a multicentre database. The aim was to identify, validate, and determine the generalizability of previously identified independent predictors of major perioperative complications in paediatric CCVR using multivariate analysis. These risk factors can then be utilised by surgical and anaesthesia teams to identify high-risk patients, potentially reduce morbidity and mortality, and therefore improve care whilst decreasing costs.
The primary aim was to determine if, in a large multicentre data set, the occurrence of major perioperative complications pertaining to CCVR is predicted by specific patient characteristic and perioperative variables. The secondary aim was to determine if outcomes, such as paediatric Intensive Care Unit length of stay and hospital length of stay, can be predicted by specific patient characteristics and perioperative variables.
Methods
We queried the multicentre Pediatric Craniofacial Surgery Perioperative Registry (PCSPR) for subjects undergoing CCVR from June 2012 (registry inception) to September 2016. Participating institutions (n¼33) obtained local institutional review board or research ethics board approval. The requirement for informed consent was waived by the local institutional internal review board at 27 institutions. A written informed consent was obtained from participating subjects at six institutions.
Complex cranial vault reconstruction was defined as frontoorbital advancement (FOA)/anterior cranial vault reconstruction, middle/posterior cranial vault reconstruction, or total cranial vault reconstruction. All procedures involved a craniotomy. The procedures identified as neuro-endoscopic procedures, spring-mediated cranioplasties, and modified Pi procedures were excluded. Data extracted included patient characteristic and surgical data, transfusion data, perioperative management data, major perioperative complications, and length of stay data. An a priori study analysis plan was submitted to the PCCG Scientific Review Committee and approved before the conduct of the analysis. The study was conducted and reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. The PCSPR data set is also the subject of other studies with different and independent research questions.
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Pediatric Craniofacial Surgery Perioperative Registry
Pediatric Craniofacial Surgery Perioperative Registry is a prospective observational registry created by the PCCG under the auspices of the Society for Pediatric Anesthesia to describe the perioperative management and outcomes of paediatric patients undergoing craniofacial surgery with the goal of using this information to improve patient care. Study data were collected and managed using REDCap electronic data capture tools hosted at the Children's Hospital of Philadelphia (Philadelphia, PA, USA). 19 Individual institutions were represented using an institution code and were not identifiable.
Data collection, entry, and validation
Collected data included patient characteristic information, perioperative fluid management and transfusion data, surgical and anaesthetic management variables, laboratory data including perioperative complete blood count and coagulation panel, the occurrence of pre-specified intra-and postoperative complications, and the length of ICU and hospital stay. Thirtythree institutions contributed data over the study time period. The reporting of perioperative complications was dependent on a detailed review of the medical record by individuals collecting data. The PCCG case report form includes a detailed and comprehensive listing of specific relevant postoperative complications. Also, a free text field was utilised to capture other more rare events or additional clinically significant major complications. Sites were required to provide quarterly reports quantifying case capture rates to ensure absence of reporting bias. The median (25th and 75th inter-quartile ranges) case capture rate across all participating institutions was 100% (98% and 100%). All participating institutions were required to report data collection and auditing processes to ensure for accuracy. 13 In addition, to ensure validity, the study principal investigator at the data coordinating centre audited data before analysis. This included scrutinising cases for omissions of critical data (e.g. age and weight) and identification of outlier data. Cross-validation of data within individual records was performed to optimise data accuracy. Queries based on omissions, outliers, and discrepancies identified through this process were aggregated and sent to site investigators for rectification.
Variables and complications
The specific variables identified were as follows: age; weight; gender; race; ASA physical status; procedure category (anterior/FOA and posterior/middle/total cranial vault reconstruction); number of synostotic sutures; craniofacial syndrome; prior craniofacial surgery; preoperative evidence of elevated intracranial pressure (ICP); intraoperative cell salvage use; anti-fibrinolytic use; perioperative transfusion protocol; duration of surgery; total intraoperative blood products transfused (ml kg À1 ); including allogeneic erythrocytes, fresh frozen plasma, cryoprecipitate, platelets, and whole blood, total intraoperative blood donor exposures, total volume of crystalloid and colloid administered, and intraoperative hypothermia (defined as core temperature <35 C).
Major perioperative (intra-and postoperative) complications (Supplementary Appendix S2) were identified amongst the complications captured in the registry through a structured a priori consensus process conducted before data analysis. Major complications were predefined before data analysis as per our previous study.
14 Five PCCG site principal investigators anonymously categorised reported complications from the PCSPR as either major or non-major through a REDCap survey. For the purposes of this study, a complication was deemed major if at least four out of five of these investigators classified it as such. In cases where three out of five investigators categorised a complication as major, two additional site principal investigators categorise the complication anonymously through a REDCap survey. If both of these additional assessors categorised a complication as major, it was classified as such. Non-major events, which could be routinely managed, are listed in Supplementary Appendix S2 and were not included in the analysis.
Statistical analysis
Patient characteristic data and data describing perioperative management were analysed using descriptive statistics. Univariate analysis examining the relationship between the occurrence of a predefined major perioperative complication and the variables listed above was performed. Independent variables with significance of P<0.1 were included in a multivariable analysis.
Univariate analysis included Fisher's exact test for comparing binary and categorical data between groups, and the ManneWhitney U-test for comparing non-normally distributed continuous variables. Multivariable logistic regression using backward selection was applied to model the association of candidate patient characteristic and perioperative variables with the occurrence of a major perioperative complication. To ensure stable odds ratios (ORs), we limited our modelling to 10 candidate variables: age, weight, race, American Society of Anethesiologists physical status, craniofacial syndrome, number of sutures, use of tranexamic acid or amino-caproic acid, surgical duration, total perioperative blood products, and site. Cut-off values of >5 hours for surgical duration and >50 ml kg À1 for total perioperative blood products given were determined using a receiver-operating-characteristic curve analysis. The likelihood ratio test was used to confirm the significance of each variable tested and included in the final multivariable model.
The HosmereLemeshow goodness-of-fit c 2 test was used to assess how well the multivariable model fits the actual data. 20 ORs and 95% confidence intervals (CIs) were calculated for each significant predictor, and adjusted for site. A probability algorithm was derived based on combinations of the final set of five predictor variables using maximum likelihood estimation. The final multivariable predictive model was evaluated by bootstrapping with 1000 resamples with replacement to determine the robustness of the model's predictive performance and accuracy with area under the curve (AUC) or c index, Brier score, and Somers's D statistics used to establish internal validity. 21, 22 Secondary outcome analysis was conducted using multiple linear regression to test the 10 co-variates listed along with the presence or absence of a major perioperative complication to determine the predictors of longer ICU and hospital length of stay. Statistical analysis was performed using Stata software release 15 (StataCorp, College Station, TX, USA), and validation of the multivariable predictive model of a major perioperative complication was conducted using the 'boot' package in R (version 3.5.1; R Development Core Team, Vienna, Austria). Twotailed values of P<0.05 were considered statistically significant.
Results
The multicentre PCSPR was queried for infants and children undergoing CCVR between June 2012 and September 2016. A total of 1814 patients from 33 institutions were analysed. The study cohort patient characteristics and perioperative details are outlined in Table 1 . The incidence of a major perioperative complication was 15% (269 of 1814 patients) (95% CI: 13e17%). This complication rate is similar to that reported previously. 14 There were no in-hospital postoperative deaths. The total perioperative blood product administration was significantly greater for the 15% of patients with major clinically significant perioperative complications (median: 42 vs 28 ml kg À1 ; P<0.001).
The patient characteristic and perioperative data are presented in Table 1 . The median age and weight of patients were 11 months and 9.5 kg, respectively. Seventy-five per cent of patients were <24 months of age and 55% weighed <10 kg. Consistent with known epidemiology of craniosynostosis, the majority of patients were male and generally healthy (ASA physical status 1 or 2). Fifteen per cent of patients had a syndromic form of craniosynostosis. For 80% of children, it was their first craniofacial operation.
The univariate analysis identified several variables associated with the occurrence of a major perioperative complication (Table 2 ). Candidate preoperative predictors included age <24 months, patient body weight <10 kg, ASA physical status, craniosynostosis syndrome, presence of a tracheostomy, elevated ICP, history of prior craniofacial surgery, and number of sutures involved. Candidate intraoperative predictors included total blood product transfusion of >50 ml kg À1 , lack of anti-fibrinolytic administration, and duration of the surgical procedure >5 h. Candidate predictors from the univariate analysis were assessed for significance in a multivariate logistic regression model. In the final multivariate model, adjusted for the effects of site/institution, independent predictors of a major perioperative complication included ASA physical status of 3 or 4 (P¼0.005), craniofacial syndrome (P¼0.008), intraoperative total blood transfusion >50 ml kg À1 (P<0.001), lack of antifibrinolytic administration (P¼0.003), and surgical time >5 h (P<0.001) ( Table 3) . The goodness-of-fit test (HosmereLemeshow) confirmed good model fit to the data (c 2 ¼9.31 on eight degrees of freedom; P¼0.317), and indicated no significant differences between observed complications and predicted perioperative complications by the model. As shown in Table 3 , the following candidate predictors increase the odds of a major perioperative complication: ASA physical status 3 or 4 (OR: 1.5; 95% CI: 1.2e2.0), craniofacial syndrome (OR: 1.6; 95% CI: 1.2e3.4), non-usage of antifibrinolytic agents (OR: 1.8; 95% CI: 1.3e2.8), total blood product transfusion >50 ml kg À1 (OR: 3.3; 95% CI: 2.4e4.6), and surgery >5 h (OR: 2.0; 95% CI: 1.4e2.9) (Fig 1) . A multivariable algorithm for predicting the occurrence of a major clinically significant perioperative complication was derived using maximum likelihood ( Table 4) . The model had good predictive accuracy as judged by the c-index or AUC (0.736; 95% CI: 0.702e0.771; P<0.001).
The bootstrap validation (using logistic regression based on 1000 resamples in R) of the multivariable algorithm adjusted for site confirmed good internal validity, as judged by the c-index or AUC (0.734) and 95% CI around the c-index (0.701e0.768). The Brier probability score is low and close to 0 (0.112), suggesting an excellent overall model performance and indicating that the probabilistic predictions of a perioperative complication based on the five multivariable predictors demonstrate excellent accuracy. Somers's D is a rank statistic related to AUC ranging from e1 to þ1 that measures predictive discrimination as to which patients will vs will not have a perioperative complication; here, our multivariable model provides good predictive discrimination (Somers's D¼0.489). ASA 1 or 2 patients have a low risk for a major perioperative complication when undergoing open cranial total perioperative blood products), and have not had an antifibrinolytic used. The multivariable analysis revealed four significant independent predictors of ICU and hospital length of stay: ASA 3 or 4, preoperative tracheostomy, total perioperative blood products >50 ml kg À1 , and major perioperative complication (all P<0.001). The effects of these predictors on extending hospital length of stay are 1 extra day for ASA 3 or 4 and for patients having >50 ml kg À1 of perioperative blood products, 5 additional days longer for patients with a preoperative tracheostomy, and an estimated 3 days longer in hospital for patients who have a major perioperative complication.
Discussion
This multicentre observational study from the PCCG identified independent predictors of major perioperative complications in paediatric CCVR surgery. Fifteen per cent of infants and children from 33 institutions undergoing CCVR over a 5 year period were reported to have a major perioperative complication. There was no reported in-hospital mortality. Independent predictors of a major perioperative complication include an ASA physical status of 3 or 4, diagnosis of a craniosynostosis syndrome, surgery duration >5 hours, intraoperative total blood transfusion of >50 ml kg
À1
, and the absence of antifibrinolytic administration. Intraoperative blood product transfusion of >50 ml kg À1 was the most significant of these, increasing the risk of a major complication by 2.5 times. Our cohort of more than 1800 cases represents the largest multicentre analysis of predictors of major perioperative complications in CCVR to date. Our 15% complication rate is similar to reported single-institution data. 4, 14 Additionally, our results corroborate prior reports that perioperative complications are more likely in patients who are more medically complex and those requiring massive intraoperative transfusion. 2, 5 This association between massive transfusion and an increased complication rate is consistent with the fact that outcomes related to blood loss remain a significant factor in perioperative morbidity in this population. Furthermore, our findings support existing data showing complications are less likely when antifibrinolytics are used, bolstering support for their expanded use in CCVR. Indeed, the 67% rate of antifibrinolytic use in our cohort highlights opportunities for improvement with respect to this intervention. The impact of patient age and the ideal timing for craniosynostosis repair has been debated in the literature since the 1990s, with simpler defects and those amenable to endoscopic-assisted repair advocated for being addressed at younger ages. 23, 24 Whilst neither age nor patient weight was predictive of major complications in our cohort, published reports show that age <9 months or weight <10 kg is related to increased perioperative complications in these children. 4, 14 One possible reason these variables did not prove to be statistically significant in our report is that smaller age and lower weight are linked to more blood loss. The relationship between younger patient age/lower weight and increased transfusion is relevant, given the association between transfusion and increased morbidity; younger patients are at a greater risk for both blood transfusion and major morbidity. 25 Therefore, expert consensus would recommend that the age at time of CCVR should be considered when feasible with elective operations planned for >10 kg and age >9 months when possible and safe. Surgical duration has shown a variable impact on perioperative complications in the craniosynostosis literature. In one report, the duration of surgery was associated with increased postoperative complications; our report also reveals higher risk with longer surgeries, specifically surgical duration over 5 hours. 4 Despite the fact that these publications span a time frame of more than 35 years, during which surgical and anaesthetic techniques have evolved, the impact of surgical duration on perioperative complications still holds true.
Study limitations
The limitations of this study include those inherent to a large multicentre clinical database analysis, including inaccurate or missing data. For example, some major complications may not have been reported, and the incidence rates presented may underestimate the true incidence for some of the variables presented. In addition, the database does not collect data or outcomes (such as surgical site infection) once the patient has been discharged from the hospital. Only in-hospital complications were recorded, as the database does not currently include information on post-discharge events or readmissions.
As with any observational data set, and despite using multivariable analysis to determine independent predictors, causeand-effect relationships cannot be established. Our primary goal was to determine independent associations for predicting clinically significant complications in CCVR rather than delineate cause-and-effect relationships. These risk factors are clinically relevant, valid, and generalisable. Whilst we attempted to control for differences amongst sites, this variable may impact complication rates and is difficult to adjust for completely. Although a patient's diagnosis and ASA physical status may not be modifiable, other predictors have greater potential to present opportunities for improvement. Interventions to reduce length of surgery or reduce blood loss and blood product transfusion may require local quality improvement protocols, and therefore, will vary by centre.
Finally, the use of antifibrinolytics has been shown to be both safe and effective in CCVR, and at this time, the benefits greatly exceed the potential risk. 26 Antifibrinolytic administration is an easily modifiable risk factor with potential for significant improvement in outcomes in this population and a target for local quality improvement endeavours. As we better understand the risk factors for perioperative complications in CCVR, opportunities exist to leverage this risk stratification to be more selective with which patients require an ICU stay, and to decrease potentially the hospital length of stay for lowest-risk patients. This could improve resource utilisation and reduce expenses for both patients and healthcare systems.
This report from the PCSPR describes a 15% incidence of major perioperative complications for paediatric CCVR. It validates previous single-centre studies, and identifies Odds ratios for the multivariable predictors of a major perioperative complication. Multivariable risk factors include ASA physical status 3 or 4, craniofacial syndrome, anti-fibrinolytic agents not used (tranexamic acid or ε-amino-caproic), surgery greater than 5 hours, total perioperative blood products transfused >50 ml kg À1 . ASA (American Society of Anesthesiologist) physical status 3: a patient with severe systemic disease and substantive functional limitations; 4: a patient with severe systemic disease that is a constant threat to life. modifiable and non-modifiable variables that may increase the propensity for a major perioperative complication. These predictors include ASA physical status 3 or 4, presence of a craniofacial syndrome, lack of antifibrinolytic treatment, intraoperative massive transfusion, and surgery duration >5 hours. Importantly, our multicentre data validate singlecentre reports on the independent association of antifibrinolytics on decreasing the incidence of a major perioperative complication. The clinically relevant predictive algorithm presented can be used as a prognostic tool to risk stratify patients, and can be used to predict which craniosynostosis patients are at an increased risk of a major postoperative event. Local quality improvement initiatives based on the risk factors identified in this study may represent an ideal strategy for improving perioperative outcomes and reducing hospital stay.
